XGEN.DE vs. FBT.L
Compare and contrast key facts about Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L).
XGEN.DE and FBT.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XGEN.DE is a passively managed fund by Xtrackers that tracks the performance of the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. It was launched on Jul 12, 2022. FBT.L is a passively managed fund by First Trust that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on May 27, 2020. Both XGEN.DE and FBT.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XGEN.DE vs. FBT.L - Performance Comparison
Loading graphics...
XGEN.DE vs. FBT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -4.14% | 7.38% | 2.95% | -5.84% | -9.98% |
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | -1.56% | 11.35% | 12.25% | 0.68% | 3.31% |
Different Trading Currencies
XGEN.DE is traded in EUR, while FBT.L is traded in GBp. To make them comparable, the FBT.L values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, XGEN.DE achieves a -4.14% return, which is significantly lower than FBT.L's -1.56% return.
XGEN.DE
- 1D
- 2.28%
- 1M
- -1.91%
- YTD
- -4.14%
- 6M
- 5.14%
- 1Y
- 11.86%
- 3Y*
- 0.68%
- 5Y*
- —
- 10Y*
- —
FBT.L
- 1D
- 2.04%
- 1M
- -0.17%
- YTD
- -1.56%
- 6M
- 11.35%
- 1Y
- 12.89%
- 3Y*
- 7.18%
- 5Y*
- 4.82%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XGEN.DE vs. FBT.L - Expense Ratio Comparison
XGEN.DE has a 0.30% expense ratio, which is lower than FBT.L's 0.60% expense ratio.
Return for Risk
XGEN.DE vs. FBT.L — Risk / Return Rank
XGEN.DE
FBT.L
XGEN.DE vs. FBT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XGEN.DE | FBT.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.57 | 0.58 | -0.01 |
Sortino ratioReturn per unit of downside risk | 0.89 | 0.97 | -0.08 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.12 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | 0.97 | 0.68 | +0.29 |
Martin ratioReturn relative to average drawdown | 2.79 | 1.57 | +1.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XGEN.DE | FBT.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.57 | 0.58 | -0.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.30 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.15 | 0.23 | -0.38 |
Correlation
The correlation between XGEN.DE and FBT.L is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
XGEN.DE vs. FBT.L - Dividend Comparison
Neither XGEN.DE nor FBT.L has paid dividends to shareholders.
Drawdowns
XGEN.DE vs. FBT.L - Drawdown Comparison
The maximum XGEN.DE drawdown since its inception was -37.58%, which is greater than FBT.L's maximum drawdown of -26.40%. Use the drawdown chart below to compare losses from any high point for XGEN.DE and FBT.L.
Loading graphics...
Drawdown Indicators
| XGEN.DE | FBT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.58% | -30.39% | -7.19% |
Max Drawdown (1Y)Largest decline over 1 year | -14.88% | -13.81% | -1.07% |
Max Drawdown (5Y)Largest decline over 5 years | — | -23.70% | — |
Current DrawdownCurrent decline from peak | -17.22% | -7.94% | -9.28% |
Average DrawdownAverage peak-to-trough decline | -19.46% | -13.73% | -5.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.61% | 6.08% | -1.47% |
Volatility
XGEN.DE vs. FBT.L - Volatility Comparison
The current volatility for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) is 6.10%, while First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) has a volatility of 7.04%. This indicates that XGEN.DE experiences smaller price fluctuations and is considered to be less risky than FBT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XGEN.DE | FBT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 7.04% | -0.94% |
Volatility (6M)Calculated over the trailing 6-month period | 13.02% | 14.66% | -1.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.88% | 22.85% | -1.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.50% | 23.08% | -4.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.50% | 24.40% | -5.90% |